Page last updated: 2024-11-02

pipobroman and Vascular Diseases

pipobroman has been researched along with Vascular Diseases in 2 studies

Pipobroman: An antineoplastic agent that acts by alkylation.
pipobroman : An N-acylpiperazine that is piperazine in which each of the nitrogens has been acylated by a 3-bromopropionoyl group. An anti-cancer drug.

Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boivin, P2
Vallée, G1
Dormont, J1
Soulier, JP1

Trials

1 trial available for pipobroman and Vascular Diseases

ArticleYear
Indications, procedure and results for the treatment of polycythaemia vera by bleeding, pipobroman and hydroxyurea.
    Nouvelle revue francaise d'hematologie, 1993, Volume: 35, Issue:5

    Topics: Acute Disease; Bloodletting; Combined Modality Therapy; Humans; Hydroxyurea; Leukemia; Phosphorus Ra

1993

Other Studies

1 other study available for pipobroman and Vascular Diseases

ArticleYear
[Present treatment of the Vaquez's disease].
    La Presse medicale, 1969, Mar-22, Volume: 77, Issue:14

    Topics: Aged; Anemia; Anticoagulants; Antineoplastic Agents; Blood Donors; Blood Volume; Bloodletting; Busul

1969